BACKGROUND: Positional supine obstructive sleep apnea syndrome (OSAS) characterizes a subgroup of patients suffering from OSAS. Several devices designed to limit supine position have been developed, but evidences of their efficacy and safety are lacking. It is unclear whether a neck-worn vibrating device could induce positional change in patients with positional OSAS. We evaluated the efficacy of a neck-worn device to induce supine avoidance positional feedback over a short-term trial in OSAS patients and its impact on sleep quality and polysomnographyc indexes. METHODS: Twenty patients with positional apneas/hypopneas were prospectively studied. Baseline characteristics of daytime somnolence and risk of sleep apnea were screened and the efficacy of a 3-day trial of supine-avoidance therapy by vibrotactile neck worn device assessed by reporting the self-perceived change in quality of sleep and performing cardio-respiratory polysomnography. Comparison between baseline and treatment results was performed. RESULTS: The neck device produced a reduction in overall apnea-hypopnea index (AHI) (mean AHI pre =16.8/h and post =4.4/h, P<0.0001), oxygen desaturation (pre =13.7/h and post =3.8/h, P<0.0001) and Respiratory Disturbance Indexes (RDI) (20.0/h vs. 5.2/h; P<0.0001).The time spent in supine position decreased from 62.1% to 33.7% of the total (P<0.001). However, the impact on the perceived quality of sleep was unpredictable. CONCLUSIONS: The neck position therapy device is effective in restricting supine sleep, improving AHI and related polysomnographic indexes. However, at least in a short-term trial, it seems unable to improve the patient's sleep quality.
BACKGROUND: Positional supine obstructive sleep apnea syndrome (OSAS) characterizes a subgroup of patients suffering from OSAS. Several devices designed to limit supine position have been developed, but evidences of their efficacy and safety are lacking. It is unclear whether a neck-worn vibrating device could induce positional change in patients with positional OSAS. We evaluated the efficacy of a neck-worn device to induce supine avoidance positional feedback over a short-term trial in OSAS patients and its impact on sleep quality and polysomnographyc indexes. METHODS: Twenty patients with positional apneas/hypopneas were prospectively studied. Baseline characteristics of daytime somnolence and risk of sleep apnea were screened and the efficacy of a 3-day trial of supine-avoidance therapy by vibrotactile neck worn device assessed by reporting the self-perceived change in quality of sleep and performing cardio-respiratory polysomnography. Comparison between baseline and treatment results was performed. RESULTS: The neck device produced a reduction in overall apnea-hypopnea index (AHI) (mean AHI pre =16.8/h and post =4.4/h, P<0.0001), oxygen desaturation (pre =13.7/h and post =3.8/h, P<0.0001) and Respiratory Disturbance Indexes (RDI) (20.0/h vs. 5.2/h; P<0.0001).The time spent in supine position decreased from 62.1% to 33.7% of the total (P<0.001). However, the impact on the perceived quality of sleep was unpredictable. CONCLUSIONS: The neck position therapy device is effective in restricting supine sleep, improving AHI and related polysomnographic indexes. However, at least in a short-term trial, it seems unable to improve the patient's sleep quality.
Authors: Irene Permut; Montserrat Diaz-Abad; Wissam Chatila; Joseph Crocetti; John P Gaughan; Gilbert E D'Alonzo; Samuel L Krachman Journal: J Clin Sleep Med Date: 2010-06-15 Impact factor: 4.062
Authors: John Fleetham; Najib Ayas; Douglas Bradley; Michael Fitzpatrick; Thomas K Oliver; Debra Morrison; Frank Ryan; Frederick Series; Robert Skomro; Willis Tsai Journal: Can Respir J Date: 2011 Jan-Feb Impact factor: 2.409
Authors: Cynthia Y Callahan; Robert G Norman; Zachary Taxin; Anne M Mooney; David M Rapoport; Indu Ayappa Journal: Sleep Date: 2013-04-01 Impact factor: 5.849
Authors: W J Randerath; J Verbraecken; S Andreas; G Bettega; A Boudewyns; E Hamans; F Jalbert; J R Paoli; B Sanner; I Smith; B A Stuck; L Lacassagne; M Marklund; J T Maurer; J L Pepin; A Valipour; T Verse; I Fietze Journal: Eur Respir J Date: 2011-03-15 Impact factor: 16.671
Authors: Michiel M Eijsvogel; Rinse Ubbink; Janita Dekker; Eline Oppersma; Frans H de Jongh; Job van der Palen; Marjolein G Brusse-Keizer Journal: J Clin Sleep Med Date: 2015-01-15 Impact factor: 4.062